GE HealthCare co-Developed Symposium:
Theranostics in Action: Precision Medicine for Today and Tomorrow
Saturday, April 6 | 12:15 PM – 1:15 PM ET | Le Westin Montréal
This accredited symposium offers a comprehensive introduction to theranostics, exploring its foundations in personalized medicine and current advances in trial research and target development. Participants will explore the operational and clinical framework of vertically integrated theranostics centers, with insights from the BAMF Health model. The discussion will focus on overcoming barriers in diverse care settings, enhancing access to precision oncology, and advancing clinical research through novel radiopharmaceutical trials.
Target Audience: Radiologist, Resident, Medical Student
This session is included with CAR 2025 registration. Lunch will be provided.
Faculty
Moderator
Speaker
Speaker
Presentations
Current Indications and Upcoming Targets
Patrick Veit-Haibach
This presentation will provide an overview about the basics of theranostics, including examples of the current trial landscape and an outlook on upcoming/currently debated targets.
At the end of this presentation, participants will be able to:
- Describe the fundamentals of theranostics, including its applications in personalized medicine.
- Review the most relevant ongoing trials and summarize the current results in theranostics.
- Identify the key emerging targets for theranostic trials and discuss their potential impact on clinical practice.
Expanding Access to Theranostics and Implementing Precision Oncology: Experience from a Comprehensive Vertically Integrated Theranostics Center
Harshad Kulkarni
This session highlights the operational and clinical framework of a comprehensive, vertically integrated theranostics center. Using the BAMF Health model, the discussion will focus on expanding access to precision oncology, addressing barriers in community and private settings, and advancing clinical research through novel radiopharmaceutical trials. Participants will gain actionable insights into optimizing care delivery, fostering collaborations, and driving innovation in theranostics.
At the end of this presentation, participants will be able to:
- Describe the key components of a vertically integrated theranostics center and their role in delivering personalized care through molecular imaging, targeted radionuclide therapy, and advanced radiopharmacy services.
- Identify strategies to overcome barriers in community settings and explore opportunities for implementing and participating in novel radiopharmaceutical clinical trials to drive innovation and expand treatment options.
- Discuss how comprehensive theranostics centers can enhance patient outcomes by integrating diagnostics with therapeutics and collaborating with healthcare providers, industry, and research organizations.
This symposium was co-developed with GE HealthCare and was planned to achieve scientific integrity, objectivity, and balance. This event is an Accredited Group Learning (Section 1) as defined by the Maintenance of Certification (MOC) program of the Royal College of Physicians ad Surgeons of Canada and approved by the Canadian Association of Radiologists. Physicians may claim a maximum of 1.0 hour.